Primary Site >> Esophagus Cancer
Gene >> PPARG
| 1. | |||||||||||
| Journal: | Anticancer Res. 2004 May-Jun;24(3a):1409-16. | ||||||||||
| Title: | The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest. | ||||||||||
| Author: | Fujii, Daisuke|Yoshida, Kazuhiro|Tanabe, Kazuaki|Hihara, Jun|Toge, Tetsuya | ||||||||||
| PMID: | 15274302 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Sci. 2006 Sep;97(9):854-60. | ||||||||||
| Title: | Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties. | ||||||||||
| Author: | Takahashi, Hirokazu|Fujita, Kouji|Fujisawa, Toshio|Yonemitsu, Kyoko|Tomimoto, Ayako|Ikeda, Ikuko|Yoneda, Masato|Masuda, Tomotaka|Schaefer, Katherine|Saubermann, Lawrence J|Shimamura, Takeshi|Saitoh, Satoru|Tachibana, Masashi|Wada, Koichiro|Nakagama, Hitos | ||||||||||
| PMID: | 16805824 | ||||||||||
| 3. | |||||||||||
| Journal: | Cancer Res. 2014 Jan 15;74(2):575-85. | ||||||||||
| Title: | Small molecule agonists of PPAR-gamma exert therapeutic effects in esophageal cancer. | ||||||||||
| Author: | Sawayama, Hiroshi|Ishimoto, Takatsugu|Watanabe, Masayuki|Yoshida, Naoya|Sugihara, Hidetaka|Kurashige, Junji|Hirashima, Kotaro|Iwatsuki, Masaaki|Baba, Yoshifumi|Oki, Eiji|Morita, Masaru|Shiose, Yoshinobu|Baba, Hideo | ||||||||||
| PMID: | 24272485 | ||||||||||
| 4. | |||||||||||
| Journal: | Transl Res. 2016 May;171:29-37.e1. | ||||||||||
| Title: | A germline predictive signature of response to platinum chemotherapy in esophageal cancer. | ||||||||||
| Author: | Rumiato, Enrica|Boldrin, Elisa|Malacrida, Sandro|Battaglia, Giorgio|Bocus, Paolo|Castoro, Carlo|Cagol, Matteo|Chiarion-Sileni, Vanna|Ruol, Alberto|Amadori, Alberto|Saggioro, Daniela | ||||||||||
| PMID: | 26772957 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 12;7(28):44572-44582. | ||||||||||
| Title: | Activation of PPARgamma suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway. | ||||||||||
| Author: | Wu, Kai|Yang, Yang|Liu, Donglei|Qi, Yu|Zhang, Chunyang|Zhao, Jia|Zhao, Song | ||||||||||
| PMID: | 27323819 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncotarget. 2016 Jul 26;7(30):48050-48058. | ||||||||||
| Title: | Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation. | ||||||||||
| Author: | Sun, Shao-Qian|Gu, Xiaobin|Gao, Xian-Shu|Li, Yi|Yu, Hongliang|Xiong, Wei|Yu, Hao|Wang, Wen|Li, Yingbo|Teng, Yingqi|Zhou, Demin | ||||||||||
| PMID: | 27385003 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncotarget. 2017 Sep 15;8(60):102277-102290. | ||||||||||
| Title: | PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis. | ||||||||||
| Author: | Ding, Hao|Chen, Yuanmei|Qiu, Hao|Liu, Chao|Wang, Yafeng|Kang, Mingqiang|Tang, Weifeng | ||||||||||
| PMID: | 29254243 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Manag Res. 2018 Aug 31;10:3149-3158. | ||||||||||
| Title: | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3. | ||||||||||
| Author: | Li, Xiaoying|Hong, Xin|Gao, Xianshu|Gu, Xiaobin|Xiong, Wei|Zhao, Jing|Yu, Hongliang|Cui, Ming|Xie, Mu|Bai, Yun|Sun, Shaoqian | ||||||||||
| PMID: | 30214307 | ||||||||||